nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Comparison of Preferences of Targeted Therapy for Metastatic Renal Cell Carcinoma between the Patient Group and Health Care Professional Group in South Korea
|
Park, Mi-Hai |
|
2012 |
15 |
6 |
p. 933-939 7 p. |
artikel |
2 |
An Evaluation Framework for Funding Drugs for Rare Diseases
|
Winquist, Eric |
|
2012 |
15 |
6 |
p. 982-986 5 p. |
artikel |
3 |
Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2
|
Roberts, Mark |
|
2012 |
15 |
6 |
p. 804-811 8 p. |
artikel |
4 |
Copyright/Subscription
|
|
|
2012 |
15 |
6 |
p. v- 1 p. |
artikel |
5 |
Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada
|
He, Jing |
|
2012 |
15 |
6 |
p. 894-906 13 p. |
artikel |
6 |
Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response
|
Gellad, Ziad F. |
|
2012 |
15 |
6 |
p. 876-886 11 p. |
artikel |
7 |
Costs of Adverse Drug Events in German Hospitals—A Microcosting Study
|
Rottenkolber, Dominik |
|
2012 |
15 |
6 |
p. 868-875 8 p. |
artikel |
8 |
Creating Models That Meet Decision Makers' Needs: A US Payer Perspective
|
Watkins, John B. |
|
2012 |
15 |
6 |
p. 792-793 2 p. |
artikel |
9 |
Dementia Care in the General Practice Setting: A Cluster Randomized Trial on the Effectiveness and Cost Impact of Three Management Strategies
|
Menn, Petra |
|
2012 |
15 |
6 |
p. 851-859 9 p. |
artikel |
10 |
Development of a Decision-Analytic Model for the Application of STR-Based Provenance Testing of Transrectal Prostate Biopsy Specimens
|
Pfeifer, John D. |
|
2012 |
15 |
6 |
p. 860-867 8 p. |
artikel |
11 |
Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5
|
Pitman, Richard |
|
2012 |
15 |
6 |
p. 828-834 7 p. |
artikel |
12 |
Editorial Board
|
|
|
2012 |
15 |
6 |
p. IFC- 1 p. |
artikel |
13 |
Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families: Observations from the Dosing Observational Study in Hemophilia
|
Neufeld, Ellis J. |
|
2012 |
15 |
6 |
p. 916-925 10 p. |
artikel |
14 |
Evaluating New Health Technologies and Disease Burden in Developed Countries
|
Catalá-López, Ferrán |
|
2012 |
15 |
6 |
p. 987-988 2 p. |
artikel |
15 |
FDA Actions Against Health Economic Promotions, 2002–2011
|
Neumann, Peter J. |
|
2012 |
15 |
6 |
p. 948-953 6 p. |
artikel |
16 |
Innovation and the Burden of Disease—Reply to Letter to the Editor by Catalá-López et al
|
Martino, Orsolina I. |
|
2012 |
15 |
6 |
p. 989- 1 p. |
artikel |
17 |
Instructions for Authors
|
|
|
2012 |
15 |
6 |
p. I-II nvt p. |
artikel |
18 |
Letter from the Editors
|
Drummond, Michael |
|
2012 |
15 |
6 |
p. 791- 1 p. |
artikel |
19 |
Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
|
Signorovitch, James E. |
|
2012 |
15 |
6 |
p. 940-947 8 p. |
artikel |
20 |
Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
|
Caro, J. Jaime |
|
2012 |
15 |
6 |
p. 796-803 8 p. |
artikel |
21 |
Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4
|
Karnon, Jonathan |
|
2012 |
15 |
6 |
p. 821-827 7 p. |
artikel |
22 |
Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
|
Briggs, Andrew H. |
|
2012 |
15 |
6 |
p. 835-842 8 p. |
artikel |
23 |
Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
|
Eddy, David M. |
|
2012 |
15 |
6 |
p. 843-850 8 p. |
artikel |
24 |
Multicriteria Decision Analysis for Including Health Interventions in the Universal Health Coverage Benefit Package in Thailand
|
Youngkong, Sitaporn |
|
2012 |
15 |
6 |
p. 961-970 10 p. |
artikel |
25 |
Orthopaedic Trauma Care in Haiti: A Cost-Effectiveness Analysis of an Innovative Surgical Residency Program
|
Carlson, Lucas C. |
|
2012 |
15 |
6 |
p. 887-893 7 p. |
artikel |
26 |
Quality-of-Life Impact of Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer Patients
|
Belmonte, Roser |
|
2012 |
15 |
6 |
p. 907-915 9 p. |
artikel |
27 |
Relative Effectiveness Assessment of Pharmaceuticals: Similarities and Differences in 29 Jurisdictions
|
Kleijnen, Sarah |
|
2012 |
15 |
6 |
p. 954-960 7 p. |
artikel |
28 |
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
|
Siebert, Uwe |
|
2012 |
15 |
6 |
p. 812-820 9 p. |
artikel |
29 |
Table of Contents
|
|
|
2012 |
15 |
6 |
p. i-iii nvt p. |
artikel |
30 |
The Inclusion of Informal Care in Applied Economic Evaluation: A Review
|
Goodrich, Kacey |
|
2012 |
15 |
6 |
p. 975-981 7 p. |
artikel |
31 |
The Utility Assessment Method Order Influences Measurement of Parents' Risk Attitude
|
Finnell, S. Maria E. |
|
2012 |
15 |
6 |
p. 926-932 7 p. |
artikel |
32 |
The View of a Model user on the ISPOR-SMDM Modeling Good Research Task Force Report
|
Berger, Marc L. |
|
2012 |
15 |
6 |
p. 794-795 2 p. |
artikel |
33 |
Using Health State Utility Values in Models Exploring the Cost-Effectiveness of Health Technologies
|
Ara, Roberta |
|
2012 |
15 |
6 |
p. 971-974 4 p. |
artikel |